Objective: To assess the impact of zinc supplementation on nutritional and biochemical parameters among children aged 12 to 59 months.
Introduction
After the sixth month of life, iron and zinc requirements of infants must be provided by complementary foods, so that the bodily demand for these micronutrients can be met. 1 Appropriate intrauterine development and exclusive breastfeeding are a guarantee that an infants requirement of iron and zinc will be met during the first six months of life. However, after this period, complementary foods should meet such demand, which may be more complicated in the second and third years of life. 2 In the last few years, zinc deficiency has been of great importance to developing countries, 3 due to the low intake of animal protein and high intake of phytates. 4, 5 The diagnosis of zinc deficiency is often based on clinical manifestations, such as dermatitis, failure to thrive, hypogonadism, dysgeusia, and anorexia. 6, 7 Measurement of plasma zinc levels is key to determining the dietary intake of zinc in infants and children. 8 There is some evidence that malnourished children gain weight more quickly when they are given zinc supplementation. 9, 10 Zinc deficiency affects the growth hormone (GH) metabolism, and may be a limiting factor in growth regulation. [11] [12] [13] Results of a meta-analysis have shown that zinc supplementation has a positive effect on the growth of malnourished children with low plasma zinc levels. 14 The status of zinc deficiency in Brazil is still enrolled in the National Child Nutritional Program, which distributes iron-fortified, milk-based formulas in São Sebastião, Distrito Federal (DF).
Methods
We carried out a randomized, blinded, placebocontrolled clinical trial in which participants received either zinc sulfate or placebo. Study participants were from lowincome families and lived in São Sebastião (DF), a town with around 70,000 inhabitants, and all of them were enrolled in the National Child Nutritional Program. The aim of this program is to provide children aged 12 to 59 months at nutritional risk with 2 kg of cows milk powder fortified with 10 mg of iron per 100 g of milk every month, given out at local health centers. In order to calculate the sample size, we estimated the prevalence of anemia to be 50% at the beginning of the study, before zinc supplementation, with a 13.5% decrease after supplementation. Given a 5% significance level and an 80% power, the sample consisted of 60 individuals, who were randomly placed in two groups. The following exclusion criteria were used: diseased children, anemic children with hemoglobin levels lower than 9.0 g/dl, children on medication or receiving supplementation, and those with parasitic disease. Mothers or surrogates were asked whether they allowed their children to participate in the study, and could decline participation or withdraw their children at any time. Before supplementation, all children were clinically examined by a pediatrician. Eligible children were randomly chosen by a health agent from the research team, who was not directly involved in the sampling. The children were placed in either of two groups according to the supplementation they received. Of every two mothers or surrogates who allowed their children to participate in the study, one child was assigned to the supplementation group and another one was placed in the control group until the total sample size was reached. The study was conducted between May and August 2002 in São Sebastião (DF).
Supplementation group
This group received 10 mg of zinc/5 ml of solution, given once a day for four months. The flask containing zinc sulfate was labeled S.
Control group
The control group received 5 ml of a syrup (placebo) a day for four months. The flask containing the syrup was labeled C.
The flasks containing placebo and zinc sulfate were identical and the taste and smell of the solutions were the same. The raw material was supplied by a pharmaceutical laboratory in São Paulo, and the solutions were prepared and supplied by a pharmaceutical laboratory in the city of Brasília (DF). The supplement was given every morning, preferably under fasting conditions. Mothers or surrogates were not instructed to change their childrens dietary habits during the study period. Information about the acceptance of milk, supplemental zinc and placebo, possible gastrointestinal symptoms (nausea, vomiting, diarrhea), and loss of appetite caused by zinc supplementation, and anthropometric measurements were recorded on the participants medical charts.
Anthropometric measurements
Children aged 24 months or less were weighed on a digital scale, whereas those aged up to 59 months were weighed on a manual anthropometric scale. Length and height were measured according to international standards. 16 The nutritional status was assessed by heightfor-age (H/A) and weight-for-height (W/H) expressed as z score, according to NCHS standards. 17 Epi-Info version 6.04 was used for data entry. A cutoff point of < -2 SD and a normal level of > -2 DP were used to determine low weight-for-height and low height-for-age.
Biochemical analysis
The children were referred to the laboratory of a health were used as cutoff points for the diagnosis of anemia. The borderline levels according to these criteria are as follows: < 11 g/dl for hemoglobin, < 30% for hematocrit, < 45 µg/dl for iron deficiency, and plasma levels lower than 70 µg/dl 19 for zinc deficiency, for both males and females.
Statistical analysis
We used SSPS version 10 for the statistical analysis.
The significance level was set at 5%, and the following tests were performed: 3. Chi-square test, when the groups were compared in terms of percentage of children with anemia at the beginning and at the end of the study.
The present study was approved by the Research Ethics Committee of Universidade de Brasília (UnB).
Results
Of 107 children, 40 voluntarily withdrew from the study and seven were excluded (two of them due to hemoglobin levels lower than 9 g/dl, three due to giardiasis, and two for being on ferrous sulfate supplementation). Of the remaining 60 children, 30 were placed in the supplementation group and 30 in the control group. In the course of the study, two children from the supplementation group withdrew. All excluded children, except those who changed address, were sent to a pediatrician for follow-up and/or treatment.
The final sample consisted of 58 children (28 in the supplementation group and 30 in the control group), 56.9% (n = 33) of whom were female and 43.1% (n = 25) of whom were male. Mean age was 23.5 (±7.6) months, and 50% of the children were aged between 12 and 24 months. Table 1 
Discussion
The poor nutritional status of children at the beginning of the study was expected, since these children were enrolled in a nutritional recovery program.
Marginal zinc deficiency has been attributed to the low intake of zinc-rich foods, as well as to the low bioavailability of zinc, especially in foods of vegetable origin. 20 In this study, serum zinc deficiency was observed in all children, but zinc levels were restored after supplementation. Zinc supplementation is recommended for short periods, mainly for individuals who are at risk of mineral depletion.
The growth of children who received zinc supplementation was not better than that observed in the control group. Twenty-five trials conducted to assess the effect of zinc supplementation on growth, using the same substance as in this study (zinc sulfate) did not show any differences between the effect on growth and the type of supplementation used. 21 Impaired growth may be due to the sample size, to the short supplementation period or to the deficiency of nutrients, other than zinc, which are also important to childrens growth; 22 previously demonstrated by an experimental animal study. 26 These data reveal that when implementing programs for micronutrient supplementation one should take the target age range into consideration, since the effects may differ. Special attention should be given to the fact that the control group in the present study consisted of children who received iron-fortified milk, which partly justifies the positive result observed in mean hemoglobin levels at the end of the study. The inhibitory effects between iron and zinc only occur at high molar concentrations (Fe:Zn,25:1). 27 As to the increase in appetite reported by the mothers, zinc supplementation may be efficient in restoring the childrens appetite for salt-containing foods, as shown in another study; 28 however, the methodology used in the present study does not allow us to confirm this finding.
Conclusion
Zinc supplementation remarkably increased the variation in hemoglobin, hematocrit, serum iron and serum zinc levels, compared to the results found for the group that only received iron-fortified milk. The improvement of some biochemical parameters in the supplementation group shows the effect of the deficiency of other micronutrients on the iron status of children. This result reveals the importance of establishing efficient policies that can tackle generalized deficiency of micronutrients or hidden hunger. The prevalence of zinc deficiency in Brazil is unknown; thus, it is necessary to investigate it further so as to establish a safe and appropriate intake of this mineral among preschoolers.
